ONCORUS INC
Share · US68236R1032 · ONCR (XNAS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -99,21 % |
Company Profile for ONCORUS INC Share
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Company Data
Name ONCORUS INC
Company Oncorus, Inc.
Symbol ONCR
Website
https://www.oncorus.com
Primary Exchange
NASDAQ

ISIN US68236R1032
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Craig R. Jalbert CIRA
Country United States of America
Currency USD
Employees 0,1 T
Address 50 Hampshire Street, 02139 Cambridge
IPO Date 2020-10-02
Dividends from 'ONCORUS INC'
Ex-Date | Dividend per Share |
---|---|
26.12.2023 | 0,14 USD |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | ONCR |
More Shares
Investors who ONCORUS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.